York Capital Management is an employee-owned hedge fund sponsor that provides investment services to high net worth individuals, families, pension and profit sharing plans, government entities, charitable organizations, endowments, foundations, and institutions. Established in 1991 and headquartered in New York City, with additional offices in London and Hong Kong, the firm primarily focuses on public equity and fixed income markets worldwide. York Capital specializes in event-driven strategies, investing in companies involved in mergers and acquisitions, distressed and restructuring situations, and special situations such as spin-offs and split-ups. The firm employs a fundamental analysis approach, utilizing event-driven strategies and bottom-up stock picking to guide its investment decisions.
Provider of outsourced linen management services intended for the healthcare and hospitality industries. The company specializes in offering linen rental services and uniform and textile rental programs to hospitals, physician offices, surgery centers and nursing homes, delivering a wide variety of comfortable and bacteria-free linens.
Provider of outpatient physical therapy services intended for customers throughout Maryland, Virginia and Washington. The company offers a wide range of treatment options including orthopedic, neurological and vestibular rehabilitation, chiropractic care and aquatic therapy, enabling its patient to get access to individualized treatment plans to achieve their specific goals.
AMC Health is knowledgeable and experienced in helping organizations achieve Patient-Centered Medical Home (PCMH) and Accountable Care Organization (ACO) objectives. AMC is a leading provider of single source, turnkey telehealth solutions that extend care in the home combining telemonitoring
Cennox Plc is a specialist international business focused on ATM services and fit-out solutions. The company offers a comprehensive range of sector-specific services designed to assist banking clients in increasing transaction levels and reducing operational costs. Cennox's team comprises industry specialists with extensive experience in managing ATM estates, providing service support, and handling signage and branding services. With a presence in 13 countries and a client base that spans over 100 locations worldwide, Cennox collaborates with many of the world's leading banks to deliver complete end-to-end solutions tailored to meet their clients' needs.
F1 Payments delivers a dynamic and diverse payments technology ecosystem with frictionless connections to facilitate transparent payments. The company is a registered ISO of Fifth Third Bank, N.A., Cincinnati, Ohio; Wells Fargo Bank, N.A. Walnut Creek, California; and Cross River Bank, Fort Lee, New Jersey.
Enovix Corporation specializes in the development and manufacturing of 3D silicon lithium-ion batteries, which feature a unique 3D cell architecture and silicon anode technology. This design enhances energy density while ensuring a high cycle life, addressing the growing energy demands of mobile devices. The company has established strategic partnerships with prominent technology firms, including Cypress Semiconductor, Intel, and Qualcomm. Founded in 2006 and headquartered in Fremont, California, Enovix operates production facilities in Fremont and Manila, Philippines. By leveraging innovative energy storage solutions, Enovix aims to improve the efficiency and safety of battery systems, effectively eliminating the risk of thermal runaway in battery-operated products.
InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery.
ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment of symptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world.
Snap Inc. operates as a camera company that focuses on multimedia communication through its flagship product, Snapchat. The Snapchat application enables users to share short videos and images, known as Snaps, and includes features such as personalized camera tools, group chats, and the ability to create and view stories. The platform also offers Discover, which curates content from publishers and creators based on user interests, as well as Snap Map, which displays location-based information and popular stories. Users can save their Snaps in a personal collection through the Memories feature. Additionally, Snap has developed Spectacles, video-sharing sunglasses that allow users to capture content directly from their perspective. Founded in 2010 and headquartered in Santa Monica, California, Snap Inc. aims to enhance social interactions through innovative camera technology.
HRI
Acquisition in 2015
HRI is a diversified restaurant holding company focused on polished casual dining and fine dining that develops and owns several restaurant concepts comprising over 90 company owned and franchised locations across the United States. In the polished casual dining category, the Company operates restaurants under the Houlihan’s brand, which offers high quality, made from scratch food at a compelling value in a contemporary atmosphere. In the fine dining category, the Company operates restaurants under the J. Gilbert's Wood-Fired Steaks, Bristol Seafood Grill and Bar/Devon's Seafood Grill and Bar brands, which offer premium steak and seafood at an approachable value in an elegant yet unpretentious setting.
Blue Sphere Corporation operates as a developer and independent power producer in the clean energy production and waste to energy markets. The company focuses on projects related to the acquisition, construction, and development of biogas facilities in the United States, Italy, the Netherlands, the United Kingdom, and Israel. It also focuses on soil amendments, compost, and other by-products. The company was formerly known as Jin Jie Corp. and changed its name to Blue Sphere Corporation in February 2010. Blue Sphere Corporation was founded in 2007 and is based in Charlotte, North Carolina.
InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery.
ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment of symptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world.
SPARTA's Policy Administration System is a state of the art, Web-based, .NET vendor developed and supported system implemented in 50 States and the District of Columbia for its targeted lines of business. The system’s featured functionality promotes efficiency, speed, ease of use, and is easily integrated into internal and external applications built with modern technology platforms.
NetManage, Inc. (NASDAQ:NETM), is a NASDAQ-listed software company that provides the fastest way to transform core applications into new Web-based business solutions. More than 10,000 customers worldwide, including the majority of the Fortune 500, have chosen NetManage for mission critical application integration.
The company was founded in 1990 and is headquartered in Cupertino, California. As of June 17, 2008, NetManage Inc. operates as a subsidiary of Micro Focus (US) Inc.
Arrowhead Pharmaceuticals is a biotechnology company based in Pasadena, California, focused on developing innovative therapies for intractable diseases with a genetic basis, particularly those involving the overproduction of specific proteins. The company's pipeline includes several RNA interference (RNAi) therapeutic candidates, such as ARO-AAT for liver diseases linked to alpha-1 antitrypsin deficiency, ARO-APOC3 for hypertriglyceridemia, and ARO-HIF2 for clear cell renal cell carcinoma. Other candidates in various stages of clinical trials aim to address conditions like chronic obstructive pulmonary disease, COVID-19, and cardiovascular diseases. Arrowhead has established collaboration agreements with Janssen Pharmaceuticals and Takeda Pharmaceuticals to further advance its RNAi therapeutics targeting liver-expressed genes. The company, originally founded as Arrowhead Research Corporation in 1989, rebranded in 2016 to reflect its focus on pharmaceutical development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.